GenMark Diagnostics, Inc.
(NASDAQ : GNMK)

( )
GNMK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.20%59.700.8%$473.50m
MDTMedtronic PLC
0.00%80.410.6%$451.00m
ALGNAlign Technology, Inc.
2.08%265.076.3%$397.96m
ISRGIntuitive Surgical, Inc.
1.84%427.512.5%$385.08m
TMOThermo Fisher Scientific Inc.
1.23%211.711.0%$340.74m
BDXBecton, Dickinson and Company
0.91%220.311.1%$331.59m
BAXBaxter International Inc.
1.39%68.371.7%$252.42m
SYKStryker Corporation
1.72%161.701.3%$248.56m
BSXBoston Scientific Corporation
2.72%27.201.1%$232.35m
EWEdwards Lifesciences Corporation
1.47%135.641.2%$199.00m
ZBHZimmer Biomet Holdings, Inc.
1.10%118.871.7%$170.47m
ABMDABIOMED, Inc.
1.70%268.453.3%$141.47m
IDXXIDEXX Laboratories, Inc.
2.04%187.613.7%$126.24m
VARVarian Medical Systems, Inc.
1.12%121.189.1%$125.60m
XRAYDENTSPLY International Inc.
0.98%57.673.0%$117.48m

Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company. The firm focuses on the development and commercializing of its its proprietary eSensor detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.